577O PRINCE: Interim analysis of the phase Ib study of 177Lu-PSMA-617 in combination with pembrolizumab for metastatic castration resistant prostate cancer (mCRPC)
暂无分享，去创建一个
L. Horvath | T. Akhurst | I. Davis | M. Hofman | L. Spain | M. Bressel | G. Kong | S. Sandhu | A. Joshua | L. Emmett | A. Kumar | R. Alipour | M. Crumbaker | Anupama Pasam | Patricia D Banks | A. Anton | R. Wallace | R. Hicks | S. Williams | E. Cassidy